Spanish pharma battles drug price cuts; 2010 pharmacy sales down for many firms
This article was originally published in Scrip
Figures from FEFE, a federation representing pharmacists in Spain, indicate that price cuts in the country have hit pharmaceutical companies hard, with eight of the top 20 firms suffering a decline in sales in 2010. Meanwhile, the pharmaceutical supply chain is presenting a united front to protest against austerity measures from both national government and regional health authorities.
You may also be interested in...
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.